Editorial: ustekinumab and Crohn's disease—what can we learn from long‐term extension studies?

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, July 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,703 followers.

Esperando más datos sobre efectividad y seguridad a largo plazo de ustekinumab https://t.co/P27gXfaAFh

RT @APandT: "Editorial: ustekinumab and Crohn's disease—what can we learn from long‐term extension studies?" by R.B. Gearry & C. Daker #us…

"Editorial: ustekinumab and Crohn's disease—what can we learn from long‐term extension studies?" by R.B. Gearry & C. Daker #ustekinumab #Crohns #IBD Read the whole Editorial FREE at https://t.co/xNpeSgG9fW "Sustained remission is required to improv…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.